GELS Stock Analysis: Buy, Sell, or Hold?
GELS - Gelteq Limited Ordinary Shares
$0.58
-0.08 (-12.17%)
▼
5d:
-3.42%
30d:
+19.74%
90d:
-21.49%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Get Alerted When GELS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GELS shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: GELS shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GELS is currently trading at $0.58, which is considered fair relative to its 30-day fair value range of $0.41 to $0.99.
Technical Outlook: Technically, GELS is in a strong downtrend. The price is approaching resistance at $0.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 12.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GELS is in a strong downtrend. The price is approaching resistance at $0.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 12.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.41 -
$0.99
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
60.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-12.2%)
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.99
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.41
Resistance Level
$0.55
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
59.4%
Share & Embed Analysis
Last updated: July 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GELS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
